We are live on ! Find out more
Man Group

Man Group Portfolio holdings

AUM $55.1B
1-Year Est. Return 24.23%
This Fund
S&P 500
This Quarter Est. Return
-1.99%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
AUM
$55.1B
AUM Growth
-$3.71B
Cap. Flow
-$1.07B
Cap. Flow %
-1.94%
Top 10 Hldgs %
15.88%
Holding
2,628
New
414
Increased
1,064
Reduced
775
Closed
261

Top Buys

Rank Stock Value
1
HDB icon
HDFC Bank
HDB
+$185M
2
PEP icon
PepsiCo
PEP
+$176M
3
TEL icon
TE Connectivity
TEL
+$166M
4
F icon
Ford
F
+$131M
5
MMM icon
3M
MMM
+$123M

Sector Composition

Rank Sector Weight
1 Technology 23.86%
2 Financials 10.33%
3 Healthcare 9.99%
4 Consumer Discretionary 9.07%
5 Industrials 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNTH icon
1201
Lantheus
LNTH
$6.82B
$4.41M 0.01%
58,131
-592
-1% -$42.5K
IDT icon
1202
IDT Corp
IDT
$1.6B
$4.4M 0.01%
89,589
+68,122
+317% +$3.37M
WD icon
1203
Walker & Dunlop
WD
$1.65B
$4.4M 0.01%
99,093
+94,323
+1,977% +$5.32M
YETI icon
1204
Yeti Holdings
YETI
$3.82B
$4.36M 0.01%
119,068
-213,957
-64% -$9.41M
FAF icon
1205
First American
FAF
$7.67B
$4.34M 0.01%
72,005
+26,577
+59% +$1.7M
CNM icon
1206
Core & Main
CNM
$8.17B
$4.34M 0.01%
87,820
-110,436
-56% -$5.95M
BLKB icon
1207
Blackbaud
BLKB
$1.5B
$4.33M 0.01%
112,233
-3,458
-3% -$173K
BSV icon
1208
Vanguard Short-Term Bond ETF
BSV
$44.6B
$4.29M 0.01%
54,717
-71,256
-57% -$5.61M
DAWN
1209
DELISTED
Day One Biopharmaceuticals
DAWN
$4.29M 0.01%
200,000
+2,904
+1% +$40.9K
CRSP icon
1210
CRISPR Therapeutics
CRSP
$4.58B
$4.28M 0.01%
90,061
+81,472
+949% +$4.3M
RBA icon
1211
RB Global
RBA
$20.8B
$4.27M 0.01%
44,578
+18,253
+69% +$1.93M
SE icon
1212
Sea Limited
SE
$61.2B
$4.27M 0.01%
51,577
-598,806
-92% -$64.2M
HASI icon
1213
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.9B
$4.27M 0.01%
116,126
+109,147
+1,564% +$3.88M
CME icon
1214
CME Group
CME
$92.2B
$4.26M 0.01%
14,430
-39,274
-73% -$11.7M
SNDX icon
1215
Syndax Pharmaceuticals
SNDX
$1.84B
$4.25M 0.01%
182,016
+137,378
+308% +$2.99M
IBP icon
1216
Installed Building Products
IBP
$6.13B
$4.25M 0.01%
16,026
+1,940
+14% +$581K
PB icon
1217
Prosperity Bancshares
PB
$8.77B
$4.23M 0.01%
62,974
-30,430
-33% -$2.13M
SLSR
1218
Solaris Resources
SLSR
$1.28B
$4.23M 0.01%
491,504
+419,404
+582% +$3.87M
RNW icon
1219
ReNew
RNW
$2.24B
$4.23M 0.01%
923,350
-1,123,430
-55% -$5.98M
WRB icon
1220
W.R. Berkley
WRB
$28B
$4.22M 0.01%
63,710
-39,260
-38% -$2.7M
KAI icon
1221
Kadant
KAI
$3.69B
$4.22M 0.01%
14,418
-18,446
-56% -$5.93M
WABC icon
1222
Westamerica Bancorp
WABC
$1.39B
$4.21M 0.01%
80,652
+44,364
+122% +$2.25M
PPG icon
1223
PPG Industries
PPG
$25.9B
$4.17M 0.01%
39,037
-104,984
-73% -$11.9M
GLXY
1224
Galaxy Digital Inc
GLXY
$4.34B
$4.17M 0.01%
226,007
+54,941
+32% +$1.31M
MLM icon
1225
Martin Marietta Materials
MLM
$33.6B
$4.17M 0.01%
7,082
-4,342
-38% -$2.77M

Similar funds

Man Group's Q1 2026 Portfolio in Review

As of Q1 2026, Man Group held 2,628 positions worth $55.1B, down 6.3% from $58.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Man Group's Q1 2026 filing shows 414 new, 1,064 increased, 775 reduced and 261 closed positions. Its largest new stake was AstraZeneca: 628,476 shares worth $122M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $418M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.

  • Man Group's largest Q1 2026 buy was AstraZeneca: 628,476 shares worth $122M.
  • Man Group added most to HDFC Bank in Q1 2026, an estimated $185M increase.
  • Man Group's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $352M.
  • Man Group fully exited State Street SPDR S&P 500 ETF Trust in Q1 2026, selling an estimated $418M.
  • Man Group's ten largest holdings make up 16% of its $55.1B portfolio in Q1 2026.
  • Man Group opened 414 new positions and closed 261 in Q1 2026.
  • Man Group's portfolio value fell 6.3% quarter-over-quarter to $55.1B.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.